About this trial
This randomized controlled study aims to investigate the effects of virtual reality (VR)-assisted gait training, in addition to Complex Decongestive Therapy (CDT), on gait parameters, physical function, quality of life, and edema levels in patients with lower extremity lymphedema. Lymphedema is a progressive condition characterized by the accumulation of protein-rich fluid due to lymphatic drainage insufficiency, leading to chronic inflammation and fibrosis. It impairs gait patterns and reduces functional mobility. VR technologies, such as the RehaWalk system, provide interactive, personalized rehabilitation environments that enhance motor learning, motivation, and adherence to treatment. The study evaluates spatiotemporal gait parameters, three-zone foot analysis (heel, midfoot, forefoot), limb circumferences, ultrasound measurements (dermis, epidermis, subcutaneous fat thickness), and patient-reported outcomes. VR-based training offers a novel, engaging approach to improve physical rehabilitation outcomes in patients with lower limb lymphedema. No significant risks are expected in this study.
Eligibility criteria
Qualifiers
Age between 18 and 65 years
Diagnosis of unilateral lower extremity lymphedema following gynecological and/or oncological surgery
Stage 2 or 3 lymphedema
Disqualifiers
Decompensated heart, lung, or kidney failure
Uncontrolled hypertension
Presence of systemic infection
Local infections in the lower extremity such as erysipelas or cellulitis
Trial design
Treatments tested in this trial
- Complex Decongestive Therapy (CDT) plus virtual reality (VR)-assisted gait training group
- Complex Decongestive Therapy alone group
Treatment groups
Locations
2Sponsors and collaborators
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Lead sponsor